Arias R, Leef G, Daimee U, et al. - To generate data on the long-term use of anticoagulation (AC) following atrial fibrillation (AF) catheter ablation, researchers surveyed 628 eligible patients from the Johns Hopkins Hospital AF database who had an AF catheter ablation between 01/01/2014 and 03/31/2018. Overall 289 responses were received. Receiving AC was admitted by 81.6% of patients with a CHA₂DS₂-VASc >2. A positive correlation of AC use with a higher CHA₂DS₂-VASc score and older age, whereas its negative link with a successful ablation, was observed. Not using AC was most commonly attributed to the recommendation by doctors to stop it following a successful ablation. A greater probability to remain on AC was noted for higher risk patients (older, higher CHA₂DS₂-VASC score). Per findings, the long-term management of AC following an ablation varied considerably, but for present, it appears prudent to continue AC on the basis of stroke risk scores until more definite data are available.